Last update:

Inflammatory disorders news

Inflammatory disorders

Mirikizumab proves safe and effective in treating Crohn's disease in Phase III trial

Results of a Phase III study conducted by an international team of researchers reveal that mirikizumab is more effective and has a favorable safety profile with fewer serious adverse events compared to a placebo for individuals ...

Diabetes

An affordable and effective nutritional approach to help reduce inflammation and prevent type 2 diabetes

A team sheds new light on the role of marine-source omega-3 supplementation in treating adipose tissue inflammation and reducing the risk for cardiometabolic diseases like type 2 diabetes.

Diseases, Conditions, Syndromes

First new treatment for asthma and COPD in half a century—new study

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes ...

Medications

First new treatment for asthma attacks in 50 years

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%. The findings, published in The Lancet Respiratory Medicine, ...

Diseases, Conditions, Syndromes

FDA approves Bimzelx for hidradenitis suppurativa

The U.S. Food and Drug Administration has approved UCB's Bimzelx (bimekizumab-bkzx) for the treatment of adults with moderate-to-severe hidradenitis suppurativa.

Diseases, Conditions, Syndromes

Air pollution linked to eczema—new research

If you live in a city or near a busy road, it might not just be your lungs bearing the brunt of air pollution—your skin could be suffering too. A recent study has found a significant link between high levels of fine particulate ...

Inflammatory disorders

Colchicine no benefit for painful knee osteoarthritis

Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), according to a study presented at the annual meeting of the American College of Rheumatology, held from ...

Inflammatory disorders

Air pollution exposure may be associated with eczema, study finds

People living in areas with higher levels of air pollution are more likely to have eczema, according to a new study published November 13, 2024 in the open-access journal PLOS ONE by Dr. Jeffrey Cohen of Yale School of Medicine, ...

Diseases, Conditions, Syndromes

FDA approves Emrosi for rosacea in adults

The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of inflammatory rosacea in adults.